Central News Agency (CNA Reporter Ho Hsiu-ling Taipei, June 29) Digital health technology platform H2U Health, with health data, AI, and preventive medicine at its core, is expected to list on the TPEx Growth Board by the end of July this year. Chairman Chen Chun-chia stated that while health media advertising currently accounts for the largest portion of revenue, with the health information platform transitioning to a SaaS subscription model, it is anticipated to surpass media advertising in the future, aiming for quarterly profits starting in the fourth quarter of next year and to turn profitable annually the year after. H2U Health held a media exchange event today. Chen Chun-chia said that H2U Health was founded in 2013, initially to provide health care for Foxconn's global employees. Its operational model primarily involves serving health examination institutions and corporate clients to establish health data entry points. By integrating digital content and interactive scenarios accumulated through the health media "Health Times" and the sports community "Running Biji," it forms a service ecosystem spanning health content, health data, and health actions, covering business-to-business (B2B), business-to-business-to-consumer (B2B2C), and business-to-consumer (B2C) businesses. H2U Health's largest shareholder is Jialun Biotechnology, under the Yonglin Foundation founded by Foxconn founder Terry Gou. The second-largest shareholder is Fwusow Food Industrial. Chen Chun-chia stated that based on current revenue breakdown, within H2U Health's core business, "health media advertising," which transmits health information through professional platforms to help brands reach target audiences, accounts for 32%. "Health information platforms" that provide employer health management platforms and health examination management platforms, and "sports event operations" each account for 19%. Health product sales and e-commerce agency operations account for 17%, and public sector p